Cargando…
Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report
BACKGROUND: Nivolumab is an anti-programmed cell death protein 1 antibody, typically used as cancer immunotherapy agent. Despite multiple clinical benefits it might cause autoimmune-related side-effects, often involving the endocrine system. To our knowledge, this is the first case of nivolumab-indu...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454065/ https://www.ncbi.nlm.nih.gov/pubmed/34544399 http://dx.doi.org/10.1186/s12902-021-00854-y |